Glioblastoma organoids derived from patient tumor tissueas a model for studying extracellular communication and microRNAs in the tumor microenvironment
Authors:
K. Součková 1,2; F. Siegl 1; M. Hýžďalová 3; K. Pěnčíková 3; T. Vaňková 1; M. Hendrych 4; P. Fadrus 5; J. Šána 1,2
Authors‘ workplace:
CEITEC – Středoevropský technologický institut, MU, Brno
1; LF MU, Brno
2; Oddělení farmakologie a toxikologie, Výzkumný ústav veterinárního lékařství, v. v. i., Brno
3; I. ústav patologie, FN u sv. Anny v Brně
4; Neurochirurgická klinika LF MU a FN Brno
5
Published in:
Klin Onkol 2026; 39(Supplementum 2): 130-133
Category:
Article
doi:
https://doi.org/10.48095/ccko20262S130
Overview
Glioblastoma (GBM) is the most aggressive primary brain tumor in adult patients and is characterized by significant cellular heterogeneity and complex interactions between tumor cells and the tumor microenvironment. Extracellular vesicles (EVs) and the microRNAs (miRNAs) they carry are important mediators of intercellular signaling and, at the same time, a potential source of biomarkers useful in the diagnosis of gliomas. Experimental models capable of preserving the biological properties of the original tumor are essential for studying these processes. In this study, we prepared glioblastoma organoids (GBOs) derived from patient tumor tissue and analyzed extracellular miRNAs present in EVs isolated from conditioned media. Concurrently, we analyzed miRNAs contained in EVs isolated from cerebrospinal fluid (CSF) of patients with gliomas of varying degrees of malignancy. A total of 12 GBOs cultures were successfully established, long-term cultured, and cryopreserved. Immunohistochemical analysis confirmed the presence of markers typical of glioblastoma cells (Nestin, GFAP, Sox2). In early-stage organoids, cell populations representing the tumor microenvironment were also detected, including endothelial cells (CD31) and microglia (CD163). In some cases, reactive astrocytes and neurons were also present. Highly abundant miRNAs were identified in EVs isolated from conditioned media of GBO and primary GBM cultures, including hsa-miR-21-5p, members of the let-7 family, hsa-miR-16-5p, hsa-miR-125b-5p, and others. These miRNAs were simultaneously detected in EVs isolated from the CSF of patients with GBM and high-grade gliomas. In contrast, miR-204-5p, which was predominantly present in CSF samples, was minimally represented in EVs from tumor cultures, suggesting a possible origin of this miRNA in non-tumor brain tissue. The presented data support the use of GBOs derived from patient tumor tissue as a suitable model for studying intercellular communication and extracellular signaling in GBM and simultaneously demonstrate the potential of EV-associated miRNAs as biomarkers of the tumor microenvironment.
Keywords:
microRNA – glioblastoma – organoid
Sources
1. Ostrom QT, Price M, Neff C et al. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the united states. Neuro-Oncology 2025; 27 (Suppl 4): iv1–iv66. doi: 10.1093/neuonc/noaf194.
2. Weller M, van den Bent M, Preusser M et al. EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood. Nat Rev Clin Oncol 2021; 18 (3): 170–186. doi: 10.1038/s41571-020-00447-z.
3. Neftel C, Laffy J, Filbin MG et al. an Integrative model of cellular states, plasticity, and genetics for glioblastoma. Cell 2019; 178 (4): 835–849. doi: 10.1016/j.cell.2019.06.024.
4. Quail DF, Joyce JA. The microenvironmental landscape of brain tumors. Cancer Cell 2017; 31 (3): 326–341. doi: 10.1016/j.ccell.2017.02.009.
5. Jacob F, Salinas RD, Zhang DY et al. A patient-derived glioblastoma organoid model and biobank recapitulates inter - and intra-tumoral heterogeneity. Cell 2020; 180 (1): 188–204. doi: 10.1016/j.cell.2019.11.036.
6. Hubert CG, Rivera M, Spangler LC et al. A three-dimensional organoid culture system derived from human glioblastomas recapitulates the hypoxic gradients and cancer stem cell heterogeneity of tumors found In vivo. Cancer Res 2016; 76 (8): 2465–2477. doi: 10.1158/0008-5472.CAN-15-2402.
7. Théry C, Witwer KW, Aikawa E et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 2018; 7 (1) : 1535750. doi: 10.1080/ 20013078.2018.1535750.
8. Ebrahimkhani S, Vafaee F, Hallal S et al. Deep sequencing of circulating exosomal microRNA allows non-invasive glioblastoma diagnosis. NPJ Precis Oncol 2018; 2 : 28. doi: 10.1038/ s41698-018-0071-0.
Labels
Paediatric clinical oncology Surgery Clinical oncologyArticle was published in
Clinical Oncology
2026 Issue Supplementum 2
-
All articles in this issue
- Editorial
- Organizační a programové výbory BOD a KNZP v roce 2026
- I. Onkologická prevence a screening
- III. Pacientské organizace a spolupráce s veřejností
- IV. Epidemiologie nádorů, klinické registry, zdravotnická informatika
- V. Follow-up, sledování onkologických pacientů
- VI. Vzdělávání, kvalita a bezpečnost v onkologické praxi
- VII. Diagnostické metody v onkologii a biobanking
- VIII. Onkochirurgie, rekonstrukční chirurgie
- IX. Radioterapeutické metody a radiofarmaka
- X. Systémová protinádorová léčba
- XI. Lokální aplikace protinádorových léčiv a vakcín, radiointervenční metody
- XII. Precizní medicína a personalizovaný přístup v onkologii
- XIII. Imunoonkologie
- XIV. Nežádoucí účinky protinádorové léčby a podpůrná léčba
- XV. Paliativní péče a symptomatická léčba
- XVI. Nutriční podpora v onkologii
- XVII. Ošetřovatelská péče a rehabilitace
- XVIII. Psychosociální péče
- XIX. Hereditární nádorové syndromy
- XX. Nádory prsu
- XXI. Nádory kůže a maligní melanom
- XXII. Nádory jícnu a žaludku
- XXIII. Nádory tlustého střeva a konečníku
- XXIV. Nádory slinivky, jater a žlučových cest
- XXV. Nádory skeletu a sarkomy
- XXVI. Nádory hlavy a krku
- XXVII. Nádory hrudníku, plic, průdušek a pleury
- XXVIII. Gynekologická onkologie
- XXIX. Uroonkologie
- XXX. Neuroendokrinní a endokrinní nádory
- XXXI. Nádory nervového systému
- XXXII. Hematoonkologie
- XXXIII. Nádory dětí, adolescentů a mladých dospělých
- XXXIV. Vývoj nových léčiv,farmakoekonomika, klinická farmacie v onkologii
- XXXV. Základní, aplikovaný a klinický výzkum v onkologii
- XXXVI. Biologie nádorů
- XXXVII. Integrativní přístupy v onkologii
- XXXVIII. Umělá inteligence v onkologii
- XXXIX. Varia (ostatní, jinde nezařazené příspěvky)
- The role of immunological markers in the diagnosis of colorectal cancer
- Glioblastoma organoids derived from patient tumor tissueas a model for studying extracellular communication and microRNAs in the tumor microenvironment
- Clinical Oncology
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue
- XX. Nádory prsu
- XIX. Hereditární nádorové syndromy
- The role of immunological markers in the diagnosis of colorectal cancer
- Editorial